OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of glycogene-type and validation of ST3GAL6 as a biomarker predicts clinical outcome and cancer cell invasion in urinary bladder cancer
Sumiya Dalangood, Zhen Zhu, Zhihui Ma, et al.
Theranostics (2020) Vol. 10, Iss. 22, pp. 10078-10091
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?
Silvia Pietrobono, Barbara Stecca
Cancers (2021) Vol. 13, Iss. 9, pp. 2014-2014
Open Access | Times Cited: 90

The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology
Marjolaine Hugonnet, Pushpita Singh, Quentin Haas, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 73

Metabolic Signaling in Cancer Metastasis
Sarah Krieg, Sara Fernandes, Constantinos Kolliopoulos, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 934-952
Open Access | Times Cited: 12

CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling
Zhengnan Huang, Yi‐Lin Yan, Zhen Zhu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 45

The novel role of circular RNA ST3GAL6 on blocking gastric cancer malignant behaviours through autophagy regulated by the FOXP2/MET/mTOR axis
Penghui Xu, Xing Zhang, Jiacheng Cao, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33

Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancer
Hassan Yousefi, Afshin Bahramy, Narges Zafari, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 33

Glycan-Lectin interactions between platelets and tumor cells drive hematogenous metastasis
Longqiang Shu, Shanyi Lin, Shumin Zhou, et al.
Platelets (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 6

Altered Glycosylation in Progression and Management of Bladder Cancer
Magdalena Wilczak, Magdalena Surman, Małgorzata Przybyło
Molecules (2023) Vol. 28, Iss. 8, pp. 3436-3436
Open Access | Times Cited: 14

Sialylation: A Cloak for Tumors to Trick the Immune System in the Microenvironment
Xiaoman Zhou, Kaijun Chi, Chairui Zhang, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 832-832
Open Access | Times Cited: 13

Identification of ST3GAL5 as a prognostic biomarker correlating with CD8+ T cell exhaustion in clear cell renal cell carcinoma
Jiakuan Liu, Meiqian Li, Jiajun Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21

Glycosphingolipids as emerging attack points in bladder cancer
Inês Moreira, Falk F. R. Buettner
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Comprehensive landscape of the ST3GAL family reveals the significance of ST3GAL6-AS1/ST3GAL6 axis on EGFR signaling in lung adenocarcinoma cell invasion
Jiaxuan Li, Yiming Long, Jingya Sun, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 17

Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment
Sagorika Nag, Abhimanyu Mandal, Aryaman Joshi, et al.
Diseases (2022) Vol. 10, Iss. 4, pp. 114-114
Open Access | Times Cited: 12

Identification and validation of sialyltransferase ST3Gal5 in bladder cancer through bioinformatics and experimental analysis
Yuli Jian, Qiwei Chen, Abdullah Al-Danakh, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112569-112569
Closed Access | Times Cited: 2

A glycosylation signature for predicting the progression and immunotherapeutic response of prostate cancer
Kailun Sun, Zhaoyan Feng, Chanyuan Fan, et al.
The Journal of Gene Medicine (2023) Vol. 25, Iss. 6
Closed Access | Times Cited: 4

LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer
Ming Yang, Xiaoyan Liu, Xiaoyue Tang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4

Glycation Interferes with the Expression of Sialyltransferases in Meningiomas
Philipp Selke, Kaya Bork, Tao Zhang, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3298-3298
Open Access | Times Cited: 8

An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer
Ranran Zhou, Jingjing Liang, Hu Tian, et al.
Disease Markers (2022) Vol. 2022, pp. 1-34
Open Access | Times Cited: 5

A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted Oligodendrogliomas
Julia Gilhodes, Adèle Meola, Bastien Cabarrou, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3067-3067
Open Access | Times Cited: 2

Integrating Bulk and Single-Cell RNA Sequencing Reveals Heterogeneity, Tumor Microenvironment, and Immunotherapeutic Efficacy Based on Sialylation-Related Genes in Bladder Cancer
Zhiyong Tan, Xiaorong Chen, Jieming Zuo, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 3399-3417
Open Access | Times Cited: 2

Identification of glycogene signature as a tool to predict the clinical outcome and immunotherapy response in breast cancer
Shuai Lin, Zengqi Tan, Hanxiao Cui, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top